Involvement of FGFR4 in Pulmonary Fibrosis Pathophysiology

被引：0
|
作者：
Ghanem, M. [1 ]
Justet, A. [1 ]
Jaillet, M. [1 ]
Hachem, M. [1 ]
Boghanim, T. [1 ]
Vadel, A. [1 ]
Mailleux, A. [1 ]
Crestani, B. [2 ]
机构：
[1] INSERM, U1152, Paris, France
[2] Hop Bichat Claude Bernard, Serv Pneumol, Paris, France
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4220
引用
收藏
页数：1
相关论文
共 50 条
  • [41] AMPLIFICATION OF FGFR4 GENE IN HUMAN BREAST AND GYNECOLOGICAL CANCERS
    JAAKKOLA, S
    SALMIKANGAS, P
    NYLUND, S
    PARTANEN, J
    ARMSTRONG, E
    PYRHONEN, S
    LEHTOVIRTA, P
    NEVANLINNA, H
    INTERNATIONAL JOURNAL OF CANCER, 1993, 54 (03) : 378 - 382
  • [42] Analysis of the FGFR4 Single Nucleotide Polymorphism in Pheochromocytomas and Paragangliomas
    Cassol, C. A.
    Asa, S. L.
    MODERN PATHOLOGY, 2011, 24 : 134A - 134A
  • [43] FGFR4 does not contribute to progression of chronic kidney disease
    Ashlee Taylor
    Christopher Yanucil
    John Musgrove
    Melody Shi
    Shintaro Ide
    Tomokazu Souma
    Christian Faul
    Myles Wolf
    Alexander Grabner
    Scientific Reports, 9
  • [44] The role of FGFR4 polymorphism in the development and progression of bladder cancer
    Yang, YC
    Lu, ML
    Cao, W
    Cai, L
    Cordon-Cardo, C
    Reute, V
    Wallerand, H
    Chopin, DK
    Rao, JY
    Zhang, ZF
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (02) : 412 - 412
  • [45] Development of potent and specific inhibitors for oncogenic kinase FGFR4
    Miranda, Renata Rezende
    Zhang, Chao
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [46] Soluble FGFR4 extracellular domain inhibits FGF19-induced activation of FGFR4 signaling and prevents nonalcoholic fatty liver disease
    Chen, Qiang
    Jiang, Yuan
    An, Yuan
    Zhao, Na
    Zhao, Yang
    Yu, Chundong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 409 (04) : 651 - 656
  • [47] FGFR4 INHIBITION IMPACTS ON GLIOBLASTOMA AGGRESSIVENESS IN VITRO AND IN VIVO
    Lotsch, Daniela
    Engelmaier, Claudia
    Allerstorfer, Sigrid
    Grusch, Michael
    Pichler, Josef
    Weis, Serge
    Hainfellner, Johannes
    Marosi, Christine
    Spiegl-Kreinecker, Sabine
    Berger, Walter
    NEURO-ONCOLOGY, 2013, 15 : 13 - 13
  • [48] Association of FGFR4 Mutation With Immunotherapy Outcomes in Patients With Cancer
    Cui, L.
    Zhang, Y.
    Zhao, Z.
    Bai, Y.
    Liu, L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S576 - S576
  • [49] Intrahepatic cholestasis of pregnancy in conjunction with a frameshift deletion in FGFR4
    Batool, Syeda Saima
    Dauer, Marc
    Weber, Susanne Nicole
    Liebe, Roman
    Lammert, Frank
    Reichert, Matthias Christian
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (03)
  • [50] Characterization of a survival pathway controlled by FGFR4 in alveolar Rhabdomyosarcoma
    Wachtel, Marco
    Schafer, Beat
    CANCER RESEARCH, 2010, 70
12345